Neurocavapiz Capsule 25 mg (Pregabalin)

Adult dose

This medication is taken orally, divided into two doses daily regardless of food. 1. Neuropathic pain 1) Peripheral neuropathic pain - Initial dose: 150 mg daily - After 3 to 7 days: may increase to 300 mg daily - If necessary, may increase to a maximum of 600 mg daily at 7-day intervals. 2) Central neuropathic pain - Initial dose: 150 mg daily - After one week: may increase to 300 mg daily.

Child dose

The safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 are insufficient, therefore, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so inform your healthcare provider immediately if you experience depression or mood changes during treatment. People allergic to any of this medication's ingredients should not take it. Diabetic patients may need to adjust their blood sugar control medications due to potential weight gain. If symptoms of angioedema such as swelling of the face or around the mouth appear, discontinue taking this medication immediately. Elderly patients should be cautious of dizziness or drowsiness that could lead to falls or injuries. Temporary blurred vision or vision changes may occur; consult a physician if such symptoms arise. When discontinuing this drug, withdrawal symptoms such as insomnia, headaches, and anxiety can occur; it is advisable to taper off under medical supervision. Patients with a history of drug abuse should use this medication cautiously due to the risk of misuse or dependence. Patients with impaired kidney function may require dosage adjustments. Caution is advised for patients with heart conditions when taking this medication. There is a risk of respiratory depression when taken with other central nervous system depressants or opioid analgesics. It is preferable to avoid use during early pregnancy due to the potential risk of congenital anomalies; women of childbearing age should use effective contraception. Nursing mothers should consider stopping breastfeeding or discontinuing the drug, as it may be excreted in breast milk. Dizziness and drowsiness may occur with this medication; caution is required when engaging in hazardous activities like driving or operating machinery. If severe skin rashes or allergic reactions occur, immediately stop taking this medication and consult a healthcare provider. In case of overdose, symptoms such as drowsiness, confusion, depression, and seizures may appear, necessitating immediate emergency treatment. This medication should be kept out of reach of children, and transferring to another container is not recommended for maintaining quality.

Serious side effects

Hives, severe swelling (angioedema, facial swelling, swelling around the mouth and upper airway), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, respiratory depression, difficulty breathing or shortness of breath, asthmatic episodes, respiratory abnormalities accompanied by coughing and fever, jaundice (yellowing of the skin or eyes).

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbed spatial orientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is advisable to store the medication at room temperature, between 15 and 30 degrees Celsius, not in excessively hot or cold places.

Appearance

A hard capsule with a colorless to light yellow powder in a light yellow upper part and a white lower part.

Package unit

30 capsules/bottle, 100 capsules/bottle